{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T09:37:23Z","timestamp":1771925843616,"version":"3.50.1"},"reference-count":51,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1097\/inf.0b013e318199d2fc","type":"journal-article","created":{"date-parts":[[2009,5,29]],"date-time":"2009-05-29T07:19:32Z","timestamp":1243581572000},"page":"521-528","source":"Crossref","is-referenced-by-count":32,"title":["Epidemiology of Pertussis and Haemophilus influenzae type b Disease in Canada With Exclusive Use of a Diphtheria-Tetanus-Acellular Pertussis-Inactivated Poliovirus-Haemophilus influenzae type b Pediatric Combination Vaccine and an Adolescent-Adult Tetanus-Diphtheria-Acellular Pertussis Vaccine"],"prefix":"10.1097","volume":"28","author":[{"given":"David P.","family":"Greenberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha","family":"Doemland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie A.","family":"Bettinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David W.","family":"Scheifele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott A.","family":"Halperin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerie","family":"Waters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kami","family":"Kandola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"ACS-1","key":"R1-13-20210202","first-page":"1","article-title":"Interchangeability of diphtheria, tetanus, acellular pertussis, polio, Haemophilus influenzae type b combination vaccines presently approved for use in Canada for children <7 years of age.","volume":"31","year":"2005","journal-title":"Can Commun Dis Rep"},{"key":"R2-13-20210202","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/01.inf.0000247055.81541.04","article-title":"The effect of changing from whole-cell to acellular pertussis vaccine on the epidemiology of hospitalized children with pertussis in Canada.","volume":"26","author":"Bettinger","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"R3-13-20210202","first-page":"172","article-title":"National Advisory Committee on Immunization. Canadian Immunization Guide. 7th ed.","volume":"93","year":"2006"},{"issue":"ACS-1","key":"R4-13-20210202","first-page":"1","article-title":"Statement on adult\/adolescent formulation of combined acellular pertussis, tetanus, and diphtheria vaccine.","volume":"26","year":"2000","journal-title":"Can Commun Dis Rep"},{"issue":"ACS-5","key":"R5-13-20210202","first-page":"1","article-title":"Prevention of pertussis in adolescents and adults.","volume":"29","year":"2003","journal-title":"Can Commun Dis Rep"},{"key":"R6-13-20210202","first-page":"235","article-title":"Pertussis in Newfoundland and Labrador: 1991\u20132004.","volume":"31","year":"2005","journal-title":"Can Commun Dis Rep"},{"key":"R7-13-20210202","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1155\/2005\/642315","article-title":"A comparison of pertussis rates in the Northwest Territories: Pre- and postacellular pertussis vaccine introduction in children and adolescents.","volume":"16","author":"Kandola","year":"2005","journal-title":"Can J Infect Dis Med Microbiol"},{"issue":"S3","key":"R8-13-20210202","first-page":"101","article-title":"Health Canada. Case definitions for diseases under national surveillance.","volume":"26","year":"2000","journal-title":"Can Commun Dis Rep"},{"key":"R9-13-20210202","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1503\/cmaj.050379","article-title":"Changing epidemiology and emerging risk groups for pertussis.","volume":"174","author":"Galanis","year":"2006","journal-title":"Can Med Assoc J"},{"key":"R10-13-20210202","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1086\/340280","article-title":"The changing age and seasonal profile of pertussis in Canada.","volume":"185","author":"Skowronski","year":"2002","journal-title":"J Infect Dis"},{"key":"R11-13-20210202","first-page":"37","article-title":"Measuring up: results from the national immunization coverage survey, 2002.","volume":"30","author":"McWha","year":"2004","journal-title":"Can Commun Dis Rep"},{"key":"R12-13-20210202","first-page":"1041","article-title":"Recent trends in pediatric Haemophilus influenzae type b infections in Canada.","volume":"154","author":"Scheifele","year":"1996","journal-title":"Can Med Assoc J"},{"key":"R13-13-20210202","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0264-410X(96)00176-4","article-title":"Estimates of the effectiveness of a whole-cell pertussis vaccine from an outbreak in an immunized population.","volume":"15","author":"Bentsi-Enchill","year":"1997","journal-title":"Vaccine"},{"key":"R14-13-20210202","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/00006454-199606000-00009","article-title":"Effectiveness of a whole cell pertussis vaccine in child care centers and schools.","volume":"15","author":"De Serres","year":"1996","journal-title":"Pediatr Infect Dis J"},{"key":"R15-13-20210202","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1056\/NEJM199602083340602","article-title":"A controlled trial of a two-component acellular, a five-component acellular and a whole-cell pertussis vaccine.","volume":"334","author":"Gustafsson","year":"1996","journal-title":"N Engl J Med"},{"key":"R16-13-20210202","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0264-410X(97)00241-7","article-title":"Safety and immunogenicity of a combined five-component pertussis-diphtheria-tetanus-inactivated poliomyelitis-Haemophilus b conjugate vaccine administered to infants at two, four, and six months of age.","volume":"16","author":"Mills","year":"1998","journal-title":"Vaccine"},{"key":"R17-13-20210202","first-page":"837","article-title":"Outbreaks of respiratory illness mistakenly attributed to pertussis\u2014New Hampshire, Massachusetts, and Tennessee, 2004\u20132006.","volume":"56","year":"2007","journal-title":"MMWR"},{"key":"R18-13-20210202","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1128\/JCM.40.8.2801-2805.2002","article-title":"Issues associated with and recommendations for using PCR to detect outbreaks of pertussis.","volume":"40","author":"Lievano","year":"2002","journal-title":"J Clin Microbiol"},{"key":"R19-13-20210202","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1086\/513432","article-title":"Evaluation of polymerase chain reaction and culture for diagnosis of pertussis in the control of a county-wide outbreak focused among adolescents and adults.","volume":"44","author":"Sotir","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R20-13-20210202","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1001\/archpediatrics.2007.7","article-title":"A countywide outbreak of pertussis: initial transmission in a high school weight room with subsequent substantial impact on adolescents and adults.","volume":"162","author":"Sotir","year":"2008","journal-title":"Arch Pediatr Adolesc Med"},{"key":"R21-13-20210202","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1542\/peds.104.4.e42","article-title":"A randomized, placebo-controlled trial of erythromycin estolate chemoprophylaxis for household contacts of children with culture-positive Bordetella pertussis infection.","volume":"104","author":"Halperin","year":"1999","journal-title":"Pediatrics"},{"key":"R22-13-20210202","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1086\/315648","article-title":"Morbidity of pertussis in adolescents and adults.","volume":"182","author":"De Serres","year":"2000","journal-title":"J Infect Dis"},{"key":"R24-13-20210202","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1045-1870(03)00036-0","article-title":"Immunization Monitoring Program, Active (IMPACT). Immunization Monitoring Program, Active: a model of active surveillance of vaccine safety.","volume":"14","author":"Scheifele","year":"2003","journal-title":"Semin Pediatr Infect Dis"},{"key":"R25-13-20210202","doi-asserted-by":"crossref","first-page":"e348","DOI":"10.1542\/peds.112.5.e348","article-title":"Decrease in hospital admissions for febrile seizures and reports of hypotonic-hyporesponsive episodes presenting to hospital emergency departments since switching to acellular pertussis vaccine in Canada: a report from IMPACT.","volume":"112","author":"Le Saux","year":"2003","journal-title":"Pediatrics"},{"key":"R26-13-20210202","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1056\/NEJMp068288","article-title":"The control of pertussis\u20132007 and beyond.","volume":"356","author":"Halperin","year":"2007","journal-title":"New Engl J Med"},{"key":"R28-13-20210202","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1503\/cmaj.1031861","article-title":"Canadian Paediatric Society\/Health Canada Immunization Monitoring Program, Active (IMPACT). Invasive Haemophilus influenzae type b infections in vaccinated and unvaccinated children in Canada, 2001\u20132003.","volume":"172","author":"Scheifele","year":"2005","journal-title":"Can Med Assoc J"},{"key":"R29-13-20210202","first-page":"314","article-title":"IMPACT highlights. Invasive Haemophilus influenzae type b cases\u20132004.","volume":"10","year":"2005","journal-title":"Paediatr Child Health"},{"key":"R31-13-20210202","doi-asserted-by":"crossref","first-page":"e421","DOI":"10.1542\/peds.2006-0287","article-title":"The Alaska Haemophilus influenzae type b experience: lessons in controlling a vaccine-preventable disease.","volume":"118","author":"Singleton","year":"2006","journal-title":"Pediatrics"},{"key":"R32-13-20210202","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3201\/eid1401.061522","article-title":"Canadian International Circumpolar Surveillance Working Group. Invasive bacterial diseases in Northern Canada.","volume":"14","author":"Degani","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"R33-13-20210202","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3201\/eid1401.070717","article-title":"International Circumpolar Surveillance, an Arctic network for surveillance of infectious diseases.","volume":"14","author":"Parkinson","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"R36-13-20210202","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1128\/JCM.44.4.1530-1535.2006","article-title":"Invasive Haemophilus influenzae in Manitoba, Canada, in the postvaccination era.","volume":"44","author":"Tsang","year":"2006","journal-title":"J Clin Microbiol"},{"key":"R37-13-20210202","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1086\/518283","article-title":"Characterization of invasive Haemophilus influenzae disease in Manitoba, Canada, 2000\u20132006: invasive disease due to non-type b strains.","volume":"44","author":"Tsang","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R38-13-20210202","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1097\/INF.0b013e31812f4f5b","article-title":"Invasive infections caused by Haemophilus influenzae serotypes in twelve Canadian IMPACT centers, 1996\u20132001.","volume":"26","author":"McConnell","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"R39-13-20210202","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3201\/eid1401.070822","article-title":"Epidemiology of Haemophilus influenzae serotype a, North American Arctic, 2000\u20132005.","volume":"14","author":"Bruce","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"R40-13-20210202","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1517\/14712598.6.8.807","article-title":"Prevention of pertussis across the age spectrum through the use of the combination vaccines PENTACEL and ADACEL.","volume":"6","author":"Halperin","year":"2006","journal-title":"Expert Opin Biol Ther"},{"key":"R42-13-20210202","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1586\/14760584.4.6.793","article-title":"A combined diphtheria, tetanus, five-component acellular pertussis, poliovirus and Haemophilus influenzae type b vaccine.","volume":"4","author":"Black","year":"2005","journal-title":"Expert Rev Vaccines"},{"key":"R43-13-20210202","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1001\/jama.293.24.3003","article-title":"Combined tetanus, diphtheria, and 5-component pertussis vaccine for use in adolescents and adults.","volume":"293","author":"Pichichero","year":"2005","journal-title":"JAMA"},{"key":"R44-13-20210202","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1097\/01.inf.0000166154.47013.47","article-title":"Overview of pertussis: focus on epidemiology, sources of infection, and long-term protection after infant vaccination.","volume":"24","author":"Edwards","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"R45-13-20210202","first-page":"81","article-title":"Summary of notifiable diseases\u2014United States, 2005.","volume":"54","year":"2007","journal-title":"MMWR"},{"issue":"RR-3","key":"R46-13-20210202","first-page":"1","article-title":"Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines. Recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"55","year":"2006","journal-title":"MMWR"},{"issue":"RR-17","key":"R47-13-20210202","first-page":"1","article-title":"Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel.","volume":"55","year":"2006","journal-title":"MMWR"},{"key":"R48-13-20210202","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1128\/CMR.18.2.326-382.2005","article-title":"Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies.","volume":"18","author":"Mattoo","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"R49-13-20210202","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1542\/peds.2004-2648","article-title":"The epidemiology of pertussis: a comparison of the epidemiology of the disease pertussis with the epidemiology of Bordetella pertussis infection.","volume":"115","author":"Cherry","year":"2005","journal-title":"Pediatrics"},{"key":"R50-13-20210202","first-page":"229","article-title":"Vaccines. 4th ed.","author":"Wenger","year":"2004"},{"key":"R51-13-20210202","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1097\/00006454-200111001-00002","article-title":"Principles of pediatric combination vaccines and practical issues related to use in clinical practice.","volume":"20","author":"Decker","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"R52-13-20210202","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0891-5520(05)70276-2","article-title":"Combination vaccines.","volume":"15","author":"Edwards","year":"2001","journal-title":"Infect Dis Clin North Am"},{"key":"R53-13-20210202","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1542\/peds.103.1.25","article-title":"An evaluation of the safety and immunogenicity of a five-component acellular pertussis, diphtheria, and tetanus toxoid vaccine (DTaP) when combined with a Haemophilus influenzae type b-tetanus toxoid conjugate vaccine (PRP-T) in Taiwanese infants.","volume":"103","author":"Lee","year":"1999","journal-title":"Pediatrics"},{"key":"R54-13-20210202","first-page":"31","article-title":"Epidemiology of hospitalized pertussis after change from whole-cell to acellular pertussis vaccine. 6th Canadian Immunization Conference 2004.","author":"Bettinger","year":"2005","journal-title":"CCDR"},{"key":"R55-13-20210202","first-page":"105","article-title":"Haemophilus influenzae type b disease at 11 pediatric centres, 1996\u20131997.","volume":"24","author":"Grewal","year":"1998","journal-title":"Can Commun Dis Rep"},{"key":"R56-13-20210202","first-page":"93","article-title":"Haemophilus influenzae type b disease control using Pentacel, Canada, 1998\u20131999.","volume":"26","author":"Scheifele","year":"2000","journal-title":"Can Commun Dis Rep"},{"key":"R57-13-20210202","first-page":"149","article-title":"Historic low Haemophilus influenzae type b case tally\u2013Canada 2000.","volume":"27","author":"Scheifele","year":"2001","journal-title":"Can Commun Dis Rep"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0b013e318199d2fc","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:26:17Z","timestamp":1620955577000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-200906000-00013"}},"subtitle":["Implications for Disease Prevention in the United States"],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e318199d2fc","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}